CME Group logo
Investments

Gradient Investments LLC Raises Inventory Place in CME Group Inc. (NASDAQ:CME)

Gradient Investments LLC boosted its holdings in CME Group Inc. (NASDAQ:CME – Get Ranking) by 45,204.9% within the fourth quarter, based on its most up-to-date submitting with the SEC. The institutional investor owned 83,361 shares of the monetary providers supplier’s inventory after shopping for a further 83,177 shares through the interval. Gradient Investments LLC’s holdings in CME Group had been value $14,018,000 as of its most up-to-date SEC submitting.

→ Purchase THIS inventory earlier than Taiwan is attacked (From Behind the Markets)

Quite a few different institutional traders have additionally purchased and offered shares of the enterprise. Vanguard Group Inc. grew its place in shares of CME Group by 1.3% through the third quarter. Vanguard Group Inc. now owns 32,767,510 shares of the monetary providers supplier’s inventory valued at $5,804,109,000 after buying a further 429,912 shares within the final quarter. Financial institution of New York Mellon Corp grew its place in shares of CME Group by 0.5% through the third quarter. Financial institution of New York Mellon Corp now owns 6,913,562 shares of the monetary providers supplier’s inventory valued at $1,224,597,000 after buying a further 31,354 shares within the final quarter. GUARDCAP ASSET MANAGEMENT Ltd grew its place in shares of CME Group by 1.1% through the second quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,195,042 shares of the monetary providers supplier’s inventory valued at $858,725,000 after buying a further 44,252 shares within the final quarter. Massachusetts Monetary Companies Co. MA lifted its holdings in shares of CME Group by 10.3% within the 2nd quarter. Massachusetts Monetary Companies Co. MA now owns 3,732,293 shares of the monetary providers supplier’s inventory valued at $764,000,000 after buying a further 349,520 shares over the past quarter. Lastly, Amundi lifted its holdings in shares of CME Group by 0.9% within the 2nd quarter. Amundi now owns 2,633,574 shares of the monetary providers supplier’s inventory valued at $525,475,000 after buying a further 23,261 shares over the past quarter. Hedge funds and different institutional traders personal 85.09% of the corporate’s inventory.

Wall Avenue Analyst Weigh In

CME has been the topic of a number of analyst studies. Credit score Suisse Group raised their value goal on shares of CME Group from $192.00 to $198.00 and gave the inventory an “outperform” ranking in a analysis word on Tuesday, February seventh. Piper Sandler decreased their value goal on shares of CME Group from $270.00 to $250.00 and set an “chubby” ranking for the corporate in a analysis word on Monday, December nineteenth. StockNews.com initiated protection on shares of CME Group in a analysis word on Thursday. They issued a “maintain” ranking for the corporate. Citigroup decreased their value goal on shares of CME Group from $214.29 to $210.00 in a analysis word on Thursday, January twelfth. Lastly, Morgan Stanley raised their value goal on shares of CME Group from $196.00 to $201.00 and gave the inventory an “equal weight” ranking in a analysis word on Monday, February thirteenth. One analysis analyst has rated the inventory with a promote ranking, 4 have given a maintain ranking and eight have given a purchase ranking to the inventory. In line with MarketBeat.com, the corporate has a consensus ranking of “Reasonable Purchase” and a median goal value of $219.83.

CME Group Buying and selling Up 2.5 %

NASDAQ:CME opened at $187.21 on Friday. CME Group Inc. has a 12 month low of $166.54 and a 12 month excessive of $251.99. The agency has a fifty day easy shifting common of $180.61 and a 200-day easy shifting common of $178.93. The corporate has a present ratio of 1.01, a fast ratio of 1.01 and a debt-to-equity ratio of 0.13. The corporate has a market capitalization of $67.34 billion, a P/E ratio of 25.33, a PEG ratio of three.59 and a beta of 0.41.

CME Group (NASDAQ:CME – Get Ranking) final posted its quarterly earnings knowledge on Wednesday, February eighth. The monetary providers supplier reported $1.92 EPS for the quarter, topping the consensus estimate of $1.90 by $0.02. CME Group had a internet margin of 53.61% and a return on fairness of 10.43%. The enterprise had income of $1.21 billion through the quarter, in comparison with the consensus estimate of $1.21 billion. Throughout the identical interval within the earlier yr, the agency posted $1.66 earnings per share. The enterprise’s income for the quarter was up 5.3% in comparison with the identical quarter final yr. On common, equities analysis analysts anticipate that CME Group Inc. will publish 8.46 earnings per share for the present yr.

CME Group Will increase Dividend

The agency additionally not too long ago introduced a quarterly dividend, which might be paid on Monday, March twenty seventh. Buyers of document on Friday, March tenth might be given a dividend of $1.10 per share. The ex-dividend date of this dividend is Thursday, March ninth. This is a rise from CME Group’s earlier quarterly dividend of $1.00. This represents a $4.40 dividend on an annualized foundation and a yield of two.35%. CME Group’s payout ratio is presently 59.54%.

About CME Group

(Get Ranking)

CME Group, Inc operates a derivatives market, which presents a variety of futures and choices merchandise for danger administration. Its exchanges supply a variety of world benchmark merchandise throughout all main asset courses based mostly on rates of interest, fairness indexes, overseas trade (FX), vitality, agricultural commodities and metals.

Learn Extra

Need to see what different hedge funds are holding CME? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Get Ranking).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

This immediate information alert was generated by narrative science expertise and monetary knowledge from MarketBeat to be able to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial crew previous to publication. Please ship any questions or feedback about this story to contact@marketbeat.com.

Earlier than you take into account CME Group, you will wish to hear this.

MarketBeat retains monitor of Wall Avenue’s top-rated and finest performing analysis analysts and the shares they advocate to their shoppers each day. MarketBeat has recognized the 5 shares that prime analysts are quietly whispering to their shoppers to purchase now earlier than the broader market catches on… and CME Group wasn’t on the listing.

Whereas CME Group presently has a “Reasonable Purchase” ranking amongst analysts, top-rated analysts imagine these 5 shares are higher buys.

View The 5 Shares Right here

Leave a Reply

Your email address will not be published. Required fields are marked *